AmerisourceBergen & Trakcel launch integrated platform for gene therapies

European Pharmaceutical Manufacturer, Willis Chandler

A new integrated technology platform has been launched to help accelerate patient access to prescribed cell and gene therapies. The platform has been launched by healthcare solutions provider AmerisourceBergen and cellular orchestration solutions leader TrakCel. Besides accelerating patient access to cell and gene therapies, the platform also aims to deliver complete visibility throughout a patient’s treatment journey.

For the full article, please visit European Pharmaceutical Manufacturer.